Results 211 to 220 of about 108,556 (242)
Some of the next articles are maybe not open access.

Relevance of total PSA and free PSA prescriptions

Annales de biologie clinique, 2018
The total PSA testing has been frequently criticized for its effectiveness in the early detection of prostate cancer. These widely resumed in and out of the medical community have led to a decrease in prescriptions. Recommendations against the use of PSA for screening have been issued in France and in most countries.
Lamy, Pierre-Jean   +4 more
openaire   +3 more sources

Pro PSA : a “pro cancer” form of PSA?

Medical Hypotheses, 2005
Pro PSA, the precursor of PSA, is an inactive 244-amino acid protein secreted by prostatic cells. Pro PSA, a distinct molecular form of free PSA in serum, includes native as well as several truncated forms. Clinical studies have recently provided evidence that pro PSA is associated with prostate cancer (PCa).
Michaël, Peyromaure   +3 more
openaire   +2 more sources

ALIGN PsA: Advancing a Multidisciplinary Approach in PsA

Seminars in Cutaneous Medicine and Surgery, 2018
Psoriasis is a chronic skin condition that is associated with several comorbidities and co-manifestations that reduce patient quality of life. Psoriatic arthritis (PsA) is a form of spondyloarthritis that is associated with psoriasis and typically involves peripheral disease, axial disease, enthesitis, dactylitis, and skin and nail lesions.
Eric W, Baum, Sergio, Schwartzman
openaire   +2 more sources

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

Urology, 1999
To enhance the specificity of prostate cancer (PCa) detection and reduce unnecessary biopsies in men with prostate-specific antigen (PSA) levels of 2.5 to 4.0 ng/mL, we prospectively evaluated various PSA-based diagnostic parameters.This study included 273 consecutive men with serum PSA of 2.5 to 4.0 ng/mL referred for early PCa detection or lower ...
B, Djavan   +6 more
openaire   +2 more sources

The PSA conundrum

Radiotherapy and Oncology, 2004
Several articles have appeared recently in Radiotherapy & Oncology [4,8,9,11,15,16] that warranted a critical reappraisal of the use of Prostate Specific Antigen (PSA) levels for determining in routine clinical practice whether or not the treatment of prostate cancer by radiotherapy was successful.
openaire   +2 more sources

SERUM-PSA, F/T PSA, PSAD, PSA-TZ AND PSA VELOCITY

The Journal of Urology, 1999
Bob Djavan   +5 more
openaire   +1 more source

?????????????????????? ?????????? ???????????????????? ???????????????? ?????????????????? pSa

2014
??????????????????????, ?????? ???????? ???????????????????? ???????????????? (smz) ???????????????? Herbaspirillum sp. ??601 ???????????????????????? ?????????????????? pSa ???? ???????? ?????????????????????? ?????????????????? pSa-Smz ??????????????. ?????????????????????? ?????????? smz ???????????????????? ???????????????????????? ?? ??????????????
openaire   +1 more source

PSA assays

The Lancet Oncology, 2000
openaire   +2 more sources

Efforts for Improving the Efficiency of PSA: PSA Density, PSA Velocity, Age-specific PSA, and Free and Complexed PSA

Türk Üroloji Seminerleri/Turkish Urology Seminars, 2013
Omer Kutlu, Ismail Turker Koksal
openaire   +1 more source

PSA ABSTRACTS

Journal of Phycology, 2009
openaire   +2 more sources

Home - About - Disclaimer - Privacy